Table 2.
Description of baseline observations in Me-Can studies of the metabolic syndrome and cancer risk
| Norway |
Austria |
Sweden |
||||||
|---|---|---|---|---|---|---|---|---|
| Variable | Oslo | NCS | CONOR | 40-year | VHM&PP | VIP | MPP | Total |
| Year of health examination (range) | 1972–73 | 1974–83 | 1995–2003 | 1994–99 | 1988–2002 | 1985–2005 | 1974–1992 | 1972–2005 |
| Subjects (n) | ||||||||
| Men | 16 760 | 25 952 | 52 181 | 60 676 | 73 213 | 38 843 | 22 241 | 289 866 |
| Women | 25 072 | 57 687 | 68 211 | 86 671 | 40 669 | 10 524 | 288 834 | |
| All | 16 760 | 51 024 | 109 868 | 128 887 | 159 884 | 79 512 | 32 765 | 578 700 |
| Age, mean (SD) | ||||||||
| Men | 44.1 (5.6) | 40.3 (6.9) | 47.7 (14.7) | 41.5 (2.0) | 42.6 (14.8) | 47.6 (9.6) | 43.7 (6.6) | 43.9 (11.1) |
| Women | 40.3 (7.0) | 47.4 (15.2) | 41.5 (1.9) | 42.8 (16.0) | 47.5 (9.6) | 49.6 (7.5) | 44.1 (12.3) | |
| All | 44.1 (5.6) | 40.3 (7.0) | 47.5 (15.0) | 41.5 (1.9) | 42.7 (15.4) | 47.6 (9.6) | 45.6 (7.4) | 44.0 (11.7) |
| Fasting status (%) | ||||||||
| <4 h | 81 | 78 | 78 | 79 | 0 | 3 | 0 | 42 |
| 4 to <8 h | 10 | 19 | 16 | 17 | 0 | 7 | 0 | 10 |
| ≥8 h | 9 | 3 | 6 | 4 | 100 | 90 | 100 | 48 |
| Data coverage (%) | ||||||||
| BMI | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Blood pressure | 100 | 100 | 100 | 100 | 100 | 99 | 100 | 100 |
| Glucose | 100 | 100 | 100 | 100 | 100 | 99 | 100 | 100 |
| Cholesterol | 100 | 100 | 100 | 100 | 100 | 99 | 100 | 100 |
| Triglycerides | 100 | 100 | 100 | 100 | 100 | 85 | 100 | 98 |